Top Tech Companies (1,865)
Don't see your company?
Create a company profile
Syntiant produces unique, always-on and low-power AI solutions that bring new levels of human voice interaction to keyboards, touch screens, mice and additional digital devices.
Arrakis has a simple but powerful vision: To extend small-molecule medicines into new realms of biology, unlocking that biology for medicine. Our approach builds on the existing sophisticated drug discovery toolkit developed for protein targets, which we are adapting and refocusing on discovering small-molecule compounds that act directly on RNA. We are pioneering new territory, with an expedition led by a team of skilled scientists and drug development leaders who are inventive yet pragmatic. We are on a bold and exciting mission, a mission not without peril, but we have an energized, collaborative, creative and fearless team – a team that has consistently breached barriers and blazed new trails in search of solutions. We are now poised to realize the promise of bringing RNA into play for small-molecule drug discovery. Pushing the frontier of this emerging field of science is gratifying, but our mission goes beyond the thrill of scientific discovery. We believe that by targeting RNA biology in new ways, we have the potential to impact millions of patients. Our platform will allow us to reach hundreds of biological targets not currently accessible to medicine, including known targets previously considered “undruggable.” Our destination is powerful new therapies for patients everywhere, by opening up a new path for discovering RNA-targeted medicines.
Elemental Machines is helping scientists improve experimental reproducibility and accelerate scientific discovery. With a new suite of connected products that harness the power of cloud-based software, machine learning and distributed sensors, Elemental Machines is giving scientists and researchers an easy, powerful and cost-effective solution fo
Mechanic Advisor is a full service marketing platform & telematics device. Mechanic Advisor helps repair shops acquire new customers and drives existing customers back to the shop to perform regular maintenance and necessary services. Each tool and service is designed to build and improve the relationship between car owner and repair shop through loyalty, trust and communication.
Medicinal Genomics is a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis. In addition to our testing platform, we provide services enabling legal cannabis cultivators and distributors to genetically identify cannabis strains so that the medical community can track those cannabis products that provide the maximum patient benefit and product reliability. The MGC Strain ID solution also enables growers to generate the foundational information for documenting and publishing their Intellectual Property for strains they develop. MGC was founded by Kevin McKernan, a world renowned leader in DNA sequencing technology, pioneering researcher and thought leader in cannabis genetics. MGC was the first company to sequence the cannabis genome and has subsequently sequenced hundreds of different cannabis strain genomes. This groundbreaking work has allowed MGC to provide the science for cannabis identification and safety in ways that profoundly enhance the scientific validation of the healing powers of this natural medicine.
With the continued growth in online learning and test-taking, education and training professionals wrestle with the challenge of maintaining exam integrity. Examity was founded in response to this issue and offers a flexible solution to include live, recorded and automated authentication and proctoring. As the recognized leader in the industry, Examity partners with more than 500 universities and corporations worldwide.
About Lambent (formerly Armored Things) Lambent is a Boston-based software company for smart space planning. Its SaaS platform leverages AI to deliver occupancy analytics for space optimization at corporate campuses and colleges. The Lambent Spaces platform leverages existing data sources such as Wi-Fi and sensors to provide anonymous and predictive analytics. The software delivers actionable intelligence so facilities professionals and space planners can make better use of the spaces they have. For more information, visit https://lambentspaces.com/.
Selux Diagnostics is developing a Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital acquired infections, and help combat the global antibiotic resistance epidemic. The CDC has cited bacterial resistance to antibiotics among the world’s deadliest and costliest health threats. Using current technologies, doctors must overprescribe powerful, broad-spectrum antibiotics for days while waiting for key diagnostic results to direct personalized therapy. SeLux NGP is the only platform capable of delivering personalized therapy results for all patients within a day of hospital entry, speeding this targeted treatment by an average of 2 days and as many as 4 days for patients infected with multi-drug resistant organisms. Selux Diagnostics was founded in 2014 by two Yale- and Harvard-trained engineers working in an improvised attic laboratory. On September 25, 2018, SeLux announced that it had signed a milestone-based contract worth up to $45 million with BARDA, a division of the U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). SeLux immediately receives $9.3 million from BARDA to fund the clinical trial necessary for SeLux NGP, SeLux's next-generation phenotyping platform. The additional $36 million will fund the development of SeLux's second-generation rapid sepsis diagnostic system. SeLux has also raised $25 million in Series B financing to support the pivotal FDA trial for SeLux’s NGP platform. The round was led by Sands Capital Ventures and included returning investors RA Capital and Schooner Capital and new investors Sands Capital and Northpond Ventures.
Discover how Excelra, a leader in biopharma data and analytics, uniquely blends scientific understanding with technological expertise. This dual mastery empowers innovative drug discovery and development, transforming research data into actionable insights for groundbreaking discovery. 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 Excelra’s interdisciplinary approach combines life science expertise with cutting-edge technology. This leads to confident, data-centric decisions, simplifying your data-driven drug discovery journey and accelerating your research. 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗖𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 At Excelra, collaboration is key. By co-creating solutions, we amplify your team's capabilities, blending scientific insight and technological acumen for more valuable discoveries and greater project control. 𝗙𝗿𝗼𝗺 𝗖𝗵𝗮𝗼𝘀 𝘁𝗼 𝗖𝗹𝗮𝗿𝗶𝘁𝘆: 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗗𝗮𝘁𝗮 We navigate the complexities of drug discovery, enhancing your success by structuring chaotic data into actionable insights, leveraging our scientific and technological prowess. 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗬𝗼𝘂𝗿 𝗚𝗼𝗮𝗹𝘀 Your goals of faster drug development and better patient outcomes are central to our mission. Committed to delivering insights and tangible progress, we ensure each data point contributes to your innovation journey, helping you 'Excelrate' towards success. 𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 Join us in redefining drug development. Our services span across the life science value chain, from molecule to market. At Excelra, each data point is a step towards a healthier future. Discover how partnering with us can 'Excelrate' your healthcare innovations.
TileDB, Inc. was spun out of MIT and Intel Labs in May 2017 as a database built on an open array engine to structure complex data for optimized cloud compute and analytics. The company's flagship product, TileDB Cloud, streamlines data management and provides extreme performance at any degree of dimensionality, and at any scale. TileDB also develops a wide range of open-source tools for interoperability across the data science and scientific computing ecosystems. TileDB is backed by Two Bear Capital, Nexus Venture Partners, Uncorrelated Ventures, Intel Capital and Big Pi. Start for free by signing up at cloud.tiledb.com.
.jpeg)
.jpg)
.jpg)
Allurion was founded in 2009 with one mission: end obesity. The Allurion Programme combines medical, digital, and nutritional approaches and engages an entire team to jumpstart weight loss and form lifelong healthy habits. Allurion has already helped thousands of people around the world lose weight, develop lifelong healthy habits, and transform their lives.
Alkermes focuses on the development of innovative medicines that seek to address unmet needs of people living with serious mental illness, addiction, and cancer. As a fully-integrated, global biopharmaceutical company, we apply our scientific expertise and proprietary technologies to develop products that are designed to make a meaningful difference in the way patients manage their disease. We are inspired by some of the most pressing public health challenges of our time to help advance innovation with the potential to improve treatment options and outcomes for patients. Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers, and broader impacted communities. In this context we also work to help support and enhance the systems through which these complex diseases are treated. We are committed to patient engagement, disease education and awareness, and advocacy for important policies that support equitable access to quality treatment. Headquartered in Dublin, Ireland, we have an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
Machine Learning for Drug Discovery. PostEra is building a modern biopharma, using machine learning to accelerate medicinal chemistry, to develop cures for diseases, faster. We've raised $26M from top investors, secured a $68M NIH partnership to prevent pandemics, and established a $260M partnership with Pfizer. We also launched and help lead the world's largest open-science initiative to find a COVID antiviral; COVID Moonshot.
Matter is a Brand Elevation Agency that integrates PR, marketing and creative services into content-rich campaigns that inspire action and build value. Founded in 2003, with eight offices spanning North America, Matter works with the world’s most innovative companies across healthcare, high-technology, consumer technology and consumer markets.
Smart Destinations is now Go City - see our corporate site at www.GoCity.com.
Airbuy Inc. is a third party B2B platform for airlines and airports to optimize ancillary and commercial revenues respectively.
Allonnia is a bio-ingenuity company™ dedicated to extracting value where others see waste. We believe that elegant solutions to the world’s biggest problems will be found in the world’s smallest organisms. So, we’re pioneering novel approaches and imaginative combinations in biotechnology and engineering to solve waste challenges in nature, using nature. We are focused on three key sectors of mining, industry, and plastics, including segments of PFAS separation and concentration, PFAS sensing, rare earth elements (REE), and oil sands process water (OSPW). We like to think of ourselves as nature's detectives, sifting through billions of biological clues to discover and deploy elegant solutions only nature itself can yield. If you've got a passion for tackling big problems, come see what we're up to. https://allonnia.com/careers/
ByDesign is the first social platform that helps people plan their lives, stay accountable, and achieve goals with family and friends. Our platform brings together robust planning features, social networking, and downloadable goal plans into one tool. ByDesign was started by two teachers with a deep passion to help their students succeed. Day in and day out, we see that achieving big goals is not only about ambition, talent or even hard work. It’s about design. Designing your day to get the most out of it. Designing your month to achieve your goals. Designing your year to move you closer to your biggest dreams. What if every action had a bigger purpose behind it? If you lived not on autopilot, but with meaning and intent? That’s what ByDesign is all about. We’re more than a tool, we’re an idea. A movement. A way to act. And most importantly, a way to live.
Cogito provides human aware technology to help professionals elevate their performance. Cogito’s contact center AI instantly analyzes hundreds of conversational behaviors to provide live in-call guidance combined with a real-time measure of customer experience. The technology is augmenting the emotional intelligence of thousands of agents in the world’s most successful enterprises – improving sales results, delivering world-class service and enhancing quality of care. Backed by OpenView Ventures, Romulus Capital and Salesforce Ventures, Cogito is headquartered in Boston, MA. At Cogito, we are united through the common goals of producing innovative technology, driving customer success, and helping people live more productive lives. Website
Hologram Sciences is a newly formed, fast-moving, consumer-focused company. We are reimagining the future of nutrition — bringing together proven science, pioneering technology, and habit-building to create personalized solutions to help people get healthier and feel better. Hologram rapidly develops and delivers new brands to market that combine advanced diagnostics, an innovative AI-driven digital experience with support from live coaches, and high-quality nutritional supplements to help people achieve their wellness goals. Hologram is backed by Royal DSM, one of the world's leading suppliers of vitamins and supplements. Our relationship with DSM provides access to leading-edge science and innovations, ingredients that are safe and proven to work, and the ability to partner with DSM customers to advance their innovation strategies. At Hologram, we are living our values and are passionate about helping people overcome obstacles to feel better every day; we are grounded in transparency and proven clinical science; and, we are committed to creating products, and an organization, that are fully inclusive and equitable. Come join us!
